United States Protein Drugs Industry 2015 Deep Market Research Report

United States Protein Drugs Industry 2015 Deep Market Research Report

Category : Pharmaceuticals
Published On : December  2015
Pages : 133



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

The United States Protein Drugs Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Protein Drugs industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Protein Drugs market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Protein Drugs industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 150 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.


Table Of Contents


1 Industry Overview
1.1 Definition and Specifications of Protein Drugs
1.2 Classification of Protein Drugs
1.2.1 Cytokines
1.2.2 Antibodies
1.2.3 Blood products
1.2.4 Peptide antibiotics
1.2.5 Vaccines
1.2.6 Enzymes
1.2.7 Peptide hormones
1.3 Applications of Protein Drugs
1.4 Industry Chain Structure of Protein Drugs
1.5 Industry Overview of Protein Drugs
1.6 Industry Policy Analysis of Protein Drugs
1.7 Industry News Analysis of Protein Drugs

2 Manufacturing Cost Structure Analysis of Protein Drugs
2.1 Bill of Materials (BOM) of Protein Drugs
2.2 BOM Price Analysis of Protein Drugs
2.3 Labor Cost Analysis of Protein Drugs
2.4 Depreciation Cost Analysis of Protein Drugs
2.5 Manufacturing Cost Structure Analysis of Protein Drugs
2.6 Manufacturing Process Analysis of Protein Drugs
2.7 China Price, Cost and Gross of Protein Drugs 2010-2015

3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2014
3.2 Manufacturing Plants Distribution of United States Key Protein Drugs Manufacturers in 2014
3.3 R&D Status and Technology Source of United States Protein Drugs Key Manufacturers in 2014
3.4 Raw Materials Sources Analysis of United States Protein Drugs Key Manufacturers in 2014

4 Production Analysis of Protein Drugs by Regions, Type, and Applications
4.1 United States Production of Protein Drugs by Regions 2010-2015
4.2 United States Production of Protein Drugs by Type 2010-2015
4.3 United States Sales of Protein Drugs by Applications 2010-2015
4.4 Price Analysis of United States Protein Drugs Key Manufacturers in 2015

4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Protein Drugs 2010-2015

5 Consumption Volume and Consumption Value Analysis of Protein Drugs by Regions
5.1 United States Consumption Volume of Protein Drugs by Regions 2010-2015
5.2 United States Consumption Value of Protein Drugs by Regions 2010-2015
5.3 United States Consumption Price Analysis of Protein Drugs by Regions 2010-2015

6 Analysis of Protein Drugs Production, Supply, Sales and Market Status 2010-2015
6.1 Capacity, Production, Sales, and Revenue of Protein Drugs 2010-2015
6.2 Production Market Share and Sales Market Share Analysis of Protein Drugs 2014-2015
6.3 Sales Overview of Protein Drugs 2010-2015
6.4 Supply, Consumption and Gap of Protein Drugs 2010-2015
6.5 Import, Export and Consumption of Protein Drugs 2010-2015
6.6 Cost, Price, Revenue and Gross Margin of Protein Drugs 2010-2015

7 Analysis of Protein Drugs Industry Key Manufacturers
7.1 Abbott laboratories
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.1.4 Abbott laboratories SWOT Analysis

7.2 Affymax
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.2.4 Affymax SWOT Analysis

7.3 Alcon
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.3.4 Alcon SWOT Analysis

7.4 Alexion pharmaceuticals
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.4.4 Alexion pharmaceuticals SWOT Analysis

7.5 Allergan
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.5.4 Allergan SWOT Analysis

7.10 Biogen
7.10.1 Company Profile
7.10.2 Product Picture and Specification
7.10.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.10.4 Biogen SWOT Analysis

7.11 Biotest pharmaceuticals
7.11.1 Company Profile
7.11.2 Product Picture and Specification
7.11.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.11.4 Biotest pharmaceuticals SWOT Analysis

7.12 Boehringer ingelheim
7.12.1 Company Profile
7.12.2 Product Picture and Specification
7.12.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.12.4 Boehringer ingelheim SWOT Analysis

7.13 Bristol-myers squibb
7.13.1 Company Profile
7.13.2 Product Picture and Specification
7.13.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.13.4 Bristol-myers squibb SWOT Analysis

7.14 Btg international
7.14.1 Company Profile
7.14.2 Product Picture and Specification
7.14.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.14.4 Btg international SWOT Analysis

7.15 Cangene
7.15.1 Company Profile
7.15.2 Product Picture and Specification
7.15.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.15.4 Cangene SWOT Analysis

7.16 Csl
7.16.1 Company Profile
7.16.2 Product Picture and Specification
7.16.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.16.4 Csl SWOT Analysis

7.17 Dendreon
7.17.1 Company Profile
7.17.2 Product Picture and Specification
7.17.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.17.4 Dendreon SWOT Analysis

7.18 Eisai
7.18.1 Company Profile
7.18.2 Product Picture and Specification
7.18.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.18.4 Eisai SWOT Analysis

7.19 Eli lilly
7.19.1 Company Profile
7.19.2 Product Picture and Specification
7.19.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.19.4 Eli lilly SWOT Analysis

7.20 Ferring pharmaceuticals
7.20.1 Company Profile
7.20.2 Product Picture and Specification
7.20.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.20.4 Ferring pharmaceuticals SWOT Analysis

7.21 Fresenius kabi
7.21.1 Company Profile
7.21.2 Product Picture and Specification
7.21.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.21.4 Fresenius kabi SWOT Analysis

7.22 Glaxosmithkline
7.22.1 Company Profile
7.22.2 Product Picture and Specification
7.22.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.22.4 Glaxosmithkline SWOT Analysis

7.23 Grifols biologicals
7.23.1 Company Profile
7.23.2 Product Picture and Specification
7.23.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.23.4 Grifols biologicals SWOT Analysis

7.24 Hoffman-la-roche
7.24.1 Company Profile
7.24.2 Product Picture and Specification
7.24.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.24.4 Hoffman-la-roche SWOT Analysis

7.25 Hospira
7.25.1 Company Profile
7.25.2 Product Picture and Specification
7.25.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.25.4 Hospira SWOT Analysis

7.26 Janssen-cilag
7.26.1 Company Profile
7.26.2 Product Picture and Specification
7.26.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.26.4 Janssen-cilag SWOT Analysis

7.27 Johnson & johnson
7.27.1 Company Profile
7.27.2 Product Picture and Specification
7.27.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.27.4 Johnson & johnson SWOT Analysis

7.28 Kamada
7.28.1 Company Profile
7.28.2 Product Picture and Specification
7.28.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.28.4 Kamada SWOT Analysis

7.29 Kedrion biopharmaceuticals, spa
7.29.1 Company Profile
7.29.2 Product Picture and Specification
7.29.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.29.4 Kedrion biopharmaceuticals, spa SWOT Analysis

7.30 Lundbeck
7.30.1 Company Profile
7.30.2 Product Picture and Specification
7.30.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.30.4 Lundbeck SWOT Analysis

7.31 Medimmune
7.31.1 Company Profile
7.31.2 Product Picture and Specification
7.31.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.31.4 Medimmune SWOT Analysis

7.32 Merck
7.32.1 Company Profile
7.32.2 Product Picture and Specification
7.32.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.32.4 Merck SWOT Analysis

7.33 Mylan
7.33.1 Company Profile
7.33.2 Product Picture and Specification
7.33.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.33.4 Mylan SWOT Analysis

7.34 Nabi biopharmaceuticals (now biota pharmaceuticals)
7.34.1 Company Profile
7.34.2 Product Picture and Specification
7.34.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.34.4 Nabi biopharmaceuticals (now biota pharmaceuticals) SWOT Analysis

7.35 Novartis
7.35.1 Company Profile
7.35.2 Product Picture and Specification
7.35.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.35.4 Novartis SWOT Analysis

7.36 Novo nordisk
7.36.1 Company Profile
7.36.2 Product Picture and Specification
7.36.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.36.4 Novo nordisk SWOT Analysis

7.37 Octapharma pharmazeutika produktionsges.m.b.h
7.37.1 Company Profile
7.37.2 Product Picture and Specification
7.37.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.37.4 Octapharma pharmazeutika produktionsges.m.b.h SWOT Analysis

7.38 Omrix biopharmaceuticals
7.38.1 Company Profile
7.38.2 Product Picture and Specification
7.38.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.38.4 Omrix biopharmaceuticals SWOT Analysis

7.39 Pfizer
7.39.1 Company Profile
7.39.2 Product Picture and Specification
7.39.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.39.4 Pfizer SWOT Analysis

7.40 Protein sciences corporation
7.40.1 Company Profile
7.40.2 Product Picture and Specification
7.40.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.40.4 Protein sciences corporation SWOT Analysis

7.41 Rare disease therapeutics
7.41.1 Company Profile
7.41.2 Product Picture and Specification
7.41.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.41.4 Rare disease therapeutics SWOT Analysis

7.42 Revo biologics
7.42.1 Company Profile
7.42.2 Product Picture and Specification
7.42.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.42.4 Revo biologics SWOT Analysis

7.43 Sandoz
7.43.1 Company Profile
7.43.2 Product Picture and Specification
7.43.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.43.4 Sandoz SWOT Analysis

7.44 Sanofi
7.44.1 Company Profile
7.44.2 Product Picture and Specification
7.44.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.44.4 Sanofi SWOT Analysis

8 Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Protein Drugs Product Types
8.5 Market Share Analysis of Different Protein Drugs Price Levels
8.6 Gross Margin Analysis of Different Protein Drugs Applications

9 Marketing Trader or Distributor Analysis of Protein Drugs
9.1 Marketing Channels Status of Protein Drugs
9.2 Traders or Distributors of Protein Drugs with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Protein Drugs
9.4 United States Import, Export and Trade Analysis of Protein Drugs

10 Development Trend of Protein Drugs Industry 2016-2021
10.1 Capacity and Production Overview of Protein Drugs 2016-2021
10.2 Production Market Share by Product Types of Protein Drugs 2016-2021
10.3 Sales and Sales Revenue Overview of Protein Drugs 2016-2021
10.4 United States Sales of Protein Drugs by Applications 2016-2021
10.5 Import, Export and Consumption of Protein Drugs 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Protein Drugs 2016-2021

11 Industry Chain Suppliers of Protein Drugs with Contact Information
11.1 Major Raw Materials Suppliers of Protein Drugs with Contact Information
11.2 Manufacturing Equipment Suppliers of Protein Drugs with Contact Information
11.3 Major Players of Protein Drugs with Contact Information
11.4 Key Consumers of Protein Drugs with Contact Information
11.5 Supply Chain Relationship Analysis of Protein Drugs

12 New Project Investment Feasibility Analysis of Protein Drugs
12.1 New Project SWOT Analysis of Protein Drugs
12.2 New Project Investment Feasibility Analysis of Protein Drugs

13 Conclusion of the United States Protein Drugs Industry 2015 Market Research Report



List Of Tables
List of Tables and Figures

Figure Picture of Protein Drugs
Table Product Specifications of Protein Drugs
Table Classification of Protein Drugs
Figure United States Sales Market Share of Protein Drugs by Product Types in 2014
Table Applications of Protein Drugs
Figure United States Sales Market Share of Protein Drugs by Applications in 2014
Figure Industry Chain Structure of Protein Drugs
Table United States Industry Overview of Protein Drugs
Table Industry Policy of Protein Drugs
Table Industry News List of Protein Drugs
Table Bill of Materials (BOM) of Protein Drugs
Table Bill of Materials (BOM) Price of Protein Drugs
Table Labor Cost of Protein Drugs
Table Depreciation Cost of Protein Drugs
Table Manufacturing Cost Structure Analysis of Protein Drugs in 2014
Figure Manufacturing Process Analysis of Protein Drugs
Table United States Price Analysis of Protein Drugs 2010-2015 (USD/Dose)
Table United States Cost Analysis of Protein Drugs 2010-2015 (USD/Dose)
Table United States Gross Analysis of Protein Drugs 2010-2015
Table Capacity (Doses) and Commercial Production Date of United States Protein Drugs Key Manufacturers in 2014
Table Manufacturing Plants Distribution of United States Key Protein Drugs Manufacturers in 2014
Table R&D Status and Technology Source of United States Protein Drugs Key Manufacturers in 2014
Table Raw Materials Sources Analysis of United States and United States Protein Drugs Key Manufacturers in 2014
Table United States Production of Protein Drugs by Regions 2010-2015 (Doses)
Table United States Production Market Share of Protein Drugs by Regions 2010-2015
Figure United States Production Market Share of Protein Drugs by Regions in 2014
Figure United States Production Market Share of Protein Drugs by Regions in 2015
Table United States Production of Protein Drugs by Types in 2010-2015 (Doses)
Table United States Production Market Share of Protein Drugs by Type in 2010-2015
Figure United States Production Market Share of Protein Drugs by Type in 2014
Figure United States Production Market Share of Protein Drugs by Type in 2015
Table United States Sales of Protein Drugs by Applications 2010-2015 (Doses)
Table United States Production Market Share of Protein Drugs by Applications 2010-2015
Figure United States Production Market Share of Protein Drugs by Applications in 2014
Figure United States Production Market Share of Protein Drugs by Applications in 2015
Table Price Comparison of United States Protein Drugs Key Manufacturers in 2015 (USD/Dose)
Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Protein Drugs 2010-2015
Table United States Consumption Volume of Protein Drugs by Regions 2010-2015 (Doses)
Table United States Consumption Volume Market Share of Protein Drugs by Regions 2010-2015 (%)
Figure United States Consumption Volume Market Share of Protein Drugs by Regions in 2014
Figure United States Consumption Volume Market Share of Protein Drugs by Regions in 2015
Table United States Consumption Value of Protein Drugs by Regions 2010-2015 (M USD)
Table United States Consumption Value Market Share of Protein Drugs by Regions 2010-2015
Figure United States Consumption Value Market Share of Protein Drugs by Regions in 2014
Figure United States Consumption Value Market Share of Protein Drugs by Regions in 2015
Table Consumption Price of Protein Drugs by Regions 2010-2015 (USD/Dose)
Table United States and Major Manufacturers Capacity of Protein Drugs 2010-2015 (Doses)
Table United States Capacity Market Share of Major Protein Drugs Manufacturers 2010-2015
Table United States and Major Manufacturers Production of Protein Drugs 2010-2015 (Doses)
Table United States Production Market Share of Major Protein Drugs Manufacturers 2010-2015
Table United States and Major Manufacturers Sales of Protein Drugs 2010-2015 (Doses)
Table United States Sales Market Share of Major Protein Drugs Manufacturers 2010-2015
Table United States and Major Manufacturers Sales Revenue of Protein Drugs 2010-2015 (M USD)
Table United States Sales Revenue Market Share of Major Protein Drugs Manufacturers 2010-2015
Figure United States Capacity (Doses), Production (Doses) and Growth Rate of Protein Drugs 2010-2015
Figure United States Capacity Utilization Rate of Protein Drugs 2010-2015
Figure United States Sales Revenue (M USD) and Growth Rate of Protein Drugs 2010-2015
Figure United States Production Market Share of Major Protein Drugs Manufacturers in 2014
Figure United States Production Market Share of Major Protein Drugs Manufacturers in 2015
Figure United States Sales Market Share of Major Protein Drugs Manufacturers in 2014
Figure United States Sales Market Share of Major Protein Drugs Manufacturers in 2015
Figure United States Sales (Doses) and Growth Rate of Protein Drugs 2010-2015
Table United States Supply, Consumption and Gap of Protein Drugs 2010-2015 (Doses)
Table United States Import, Export and Consumption of Protein Drugs 2010-2015 (Doses)
Table Price of United States Protein Drugs Major Manufacturers 2010-2015 (USD/Dose)
Table Gross Margin of United States Protein Drugs Major Manufacturers 2010-2015
Table United States and Major Manufacturers Revenue of Protein Drugs 2010-2015 (M USD)
Table United States Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Protein Drugs 2010-2015
Table Abbott laboratories Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Protein Drugs Picture and Specifications of Abbott laboratories
Table Protein Drugs Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Abbott laboratories 2010-2015
Figure Protein Drugs Capacity (Doses), Production (Doses) and Growth Rate of Abbott laboratories 2010-2015
Figure Protein Drugs Production (Doses) and United States Market Share of Abbott laboratories 2010-2015
Table Abbott laboratories Protein Drugs SWOT Analysis
Table Affymax Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Protein Drugs Picture and Specifications of Affymax
Table Protein Drugs Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Affymax 2010-2015
Figure Protein Drugs Capacity (Doses), Production (Doses) and Growth Rate of Affymax 2010-2015
Figure Protein Drugs Production (Doses) and United States Market Share of Affymax 2010-2015
Table Affymax Protein Drugs SWOT Analysis
Table Alcon Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Protein Drugs Picture and Specifications of Alcon
Table Protein Drugs Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Alcon 2010-2015
Figure Protein Drugs Capacity (Doses), Production (Doses) and Growth Rate of Alcon 2010-2015
Figure Protein Drugs Production (Doses) and United States Market Share of Alcon 2010-2015
Table Alcon Protein Drugs SWOT Analysis
Table Alexion pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Protein Drugs Picture and Specifications of Alexion pharmaceuticals
Table Protein Drugs Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Alexion pharmaceuticals 2010-2015
Figure Protein Drugs Capacity (Doses), Production (Doses) and Growth Rate of Alexion pharmaceuticals 2010-2015
Figure Protein Drugs Production (Doses) and United States Market Share of Alexion pharmaceuticals 2010-2015
Table Alexion pharmaceuticals Protein Drugs SWOT Analysis
Table Allergan Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Protein Drugs Picture and Specifications of Allergan
Table Protein Drugs Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Allergan 2010-2015
Figure Protein Drugs Capacity (Doses), Production (Doses) and Growth Rate of Allergan 2010-2015
Figure Protein Drugs Production (Doses) and United States Market Share of Allergan 2010-2015
Table Allergan Protein Drugs SWOT Analysis
Table Biogen Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Protein Drugs Picture and Specifications of Biogen
Table Protein Drugs Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Biogen 2010-2015
Figure Protein Drugs Capacity (Doses), Production (Doses) and Growth Rate of Biogen 2010-2015
Figure Protein Drugs Production (Doses) and United States Market Share of Biogen 2010-2015
Table Biogen Protein Drugs SWOT Analysis
Table Biotest pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Protein Drugs Picture and Specifications of Biotest pharmaceuticals
Table Protein Drugs Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Biotest pharmaceuticals 2010-2015
Figure Protein Drugs Capacity (Doses), Production (Doses) and Growth Rate of Biotest pharmaceuticals 2010-2015
Figure Protein Drugs Production (Doses) and United States Market Share of Biotest pharmaceuticals 2010-2015
Table Biotest pharmaceuticals Protein Drugs SWOT Analysis
Table Boehringer ingelheim Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Protein Drugs Picture and Specifications of Boehringer ingelheim
Table Protein Drugs Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Boehringer ingelheim 2010-2015
Figure Protein Drugs Capacity (Doses), Production (Doses) and Growth Rate of Boehringer ingelheim 2010-2015
Figure Protein Drugs Production (Doses) and United States Market Share of Boehringer ingelheim 2010-2015
Table Boehringer ingelheim Protein Drugs SWOT Analysis
Table Bristol-myers squibb Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Protein Drugs Picture and Specifications of Bristol-myers squibb
Table Protein Drugs Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Bristol-myers squibb 2010-2015
Figure Protein Drugs Capacity (Doses), Production (Doses) and Growth Rate of Bristol-myers squibb 2010-2015
Figure Protein Drugs Production (Doses) and United States Market Share of Bristol-myers squibb 2010-2015
Table Bristol-myers squibb Protein Drugs SWOT Analysis
Table Btg international Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Protein Drugs Picture and Specifications of Btg international
Table Protein Drugs Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Btg international 2010-2015
Figure Protein Drugs Capacity (Doses), Production (Doses) and Growth Rate of Btg international 2010-2015
Figure Protein Drugs Production (Doses) and United States Market Share of Btg international 2010-2015
Table Btg international Protein Drugs SWOT Analysis
Table Cangene Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Protein Drugs Picture and Specifications of Cangene
Table Protein Drugs Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Cangene 2010-2015
Figure Protein Drugs Capacity (Doses), Production (Doses) and Growth Rate of Cangene 2010-2015
Figure Protein Drugs Production (Doses) and United States Market Share of Cangene 2010-2015
Table Cangene Protein Drugs SWOT Analysis
Table Csl Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Protein Drugs Picture and Specifications of Csl
Table Protein Drugs Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Csl 2010-2015
Figure Protein Drugs Capacity (Doses), Production (Doses) and Growth Rate of Csl 2010-2015
Figure Protein Drugs Production (Doses) and United States Market Share of Csl 2010-2015
Table Csl Protein Drugs SWOT Analysis
Table Dendreon Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Protein Drugs Picture and Specifications of Dendreon
Table Protein Drugs Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Dendreon 2010-2015
Figure Protein Drugs Capacity (Doses), Production (Doses) and Growth Rate of Dendreon 2010-2015
Figure Protein Drugs Production (Doses) and United States Market Share of Dendreon 2010-2015
Table Dendreon Protein Drugs SWOT Analysis
Table Eisai Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Protein Drugs Picture and Specifications of Eisai
Table Protein Drugs Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Eisai 2010-2015
Figure Protein Drugs Capacity (Doses), Production (Doses) and Growth Rate of Eisai 2010-2015
Figure Protein Drugs Production (Doses) and United States Market Share of Eisai 2010-2015
Table Eisai Protein Drugs SWOT Analysis
Table Eli lilly Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Protein Drugs Picture and Specifications of Eli lilly
Table Protein Drugs Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Eli lilly 2010-2015
Figure Protein Drugs Capacity (Doses), Production (Doses) and Growth Rate of Eli lilly 2010-2015
Figure Protein Drugs Production (Doses) and United States Market Share of Eli lilly 2010-2015
Table Eli lilly Protein Drugs SWOT Analysis
Table Ferring pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Protein Drugs Picture and Specifications of Ferring pharmaceuticals
Table Protein Drugs Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Ferring pharmaceuticals 2010-2015
Figure Protein Drugs Capacity (Doses), Production (Doses) and Growth Rate of Ferring pharmaceuticals 2010-2015
Figure Protein Drugs Production (Doses) and United States Market Share of Ferring pharmaceuticals 2010-2015
Table Ferring pharmaceuticals Protein Drugs SWOT Analysis
Table Fresenius kabi Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Protein Drugs Picture and Specifications of Fresenius kabi
Table Protein Drugs Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Fresenius kabi 2010-2015
Figure Protein Drugs Capacity (Doses), Production (Doses) and Growth Rate of Fresenius kabi 2010-2015
Figure Protein Drugs Production (Doses) and United States Market Share of Fresenius kabi 2010-2015
Table Fresenius kabi Protein Drugs SWOT Analysis
Table Glaxosmithkline Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Protein Drugs Picture and Specifications of Glaxosmithkline
Table Protein Drugs Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Glaxosmithkline 2010-2015
Figure Protein Drugs Capacity (Doses), Production (Doses) and Growth Rate of Glaxosmithkline 2010-2015
Figure Protein Drugs Production (Doses) and United States Market Share of Glaxosmithkline 2010-2015
Table Glaxosmithkline Protein Drugs SWOT Analysis
Table Grifols biologicals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Protein Drugs Picture and Specifications of Grifols biologicals
Table Protein Drugs Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Grifols biologicals 2010-2015
Figure Protein Drugs Capacity (Doses), Production (Doses) and Growth Rate of Grifols biologicals 2010-2015
Figure Protein Drugs Production (Doses) and United States Market Share of Grifols biologicals 2010-2015
Table Grifols biologicals Protein Drugs SWOT Analysis
Table Hoffman-la-roche Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Protein Drugs Picture and Specifications of Hoffman-la-roche
Table Protein Drugs Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Hoffman-la-roche 2010-2015
Figure Protein Drugs Capacity (Doses), Production (Doses) and Growth Rate of Hoffman-la-roche 2010-2015
Figure Protein Drugs Production (Doses) and United States Market Share of Hoffman-la-roche 2010-2015
Table Hoffman-la-roche Protein Drugs SWOT Analysis
Table Hospira Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Protein Drugs Picture and Specifications of Hospira
Table Protein Drugs Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Hospira 2010-2015
Figure Protein Drugs Capacity (Doses), Production (Doses) and Growth Rate of Hospira 2010-2015
Figure Protein Drugs Production (Doses) and United States Market Share of Hospira 2010-2015
Table Hospira Protein Drugs SWOT Analysis
Table Janssen-cilag Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Protein Drugs Picture and Specifications of Janssen-cilag
Table Protein Drugs Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Janssen-cilag 2010-2015
Figure Protein Drugs Capacity (Doses), Production (Doses) and Growth Rate of Janssen-cilag 2010-2015
Figure Protein Drugs Production (Doses) and United States Market Share of Janssen-cilag 2010-2015
Table Janssen-cilag Protein Drugs SWOT Analysis
Table Johnson & johnson Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Protein Drugs Picture and Specifications of Johnson & johnson
Table Protein Drugs Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Johnson & johnson 2010-2015
Figure Protein Drugs Capacity (Doses), Production (Doses) and Growth Rate of Johnson & johnson 2010-2015
Figure Protein Drugs Production (Doses) and United States Market Share of Johnson & johnson 2010-2015
Table Johnson & johnson Protein Drugs SWOT Analysis
Table Kamada Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Protein Drugs Picture and Specifications of Kamada
Table Protein Drugs Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Kamada 2010-2015
Figure Protein Drugs Capacity (Doses), Production (Doses) and Growth Rate of Kamada 2010-2015
Figure Protein Drugs Production (Doses) and United States Market Share of Kamada 2010-2015
Table Kamada Protein Drugs SWOT Analysis
Table Kedrion biopharmaceuticals, spa Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Protein Drugs Picture and Specifications of Kedrion biopharmaceuticals, spa
Table Protein Drugs Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Kedrion biopharmaceuticals, spa 2010-2015
Figure Protein Drugs Capacity (Doses), Production (Doses) and Growth Rate of Kedrion biopharmaceuticals, spa 2010-2015
Figure Protein Drugs Production (Doses) and United States Market Share of Kedrion biopharmaceuticals, spa 2010-2015
Table Kedrion biopharmaceuticals, spa Protein Drugs SWOT Analysis
Table Lundbeck Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Protein Drugs Picture and Specifications of Lundbeck
Table Protein Drugs Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Lundbeck 2010-2015
Figure Protein Drugs Capacity (Doses), Production (Doses) and Growth Rate of Lundbeck 2010-2015
Figure Protein Drugs Production (Doses) and United States Market Share of Lundbeck 2010-2015
Table Lundbeck Protein Drugs SWOT Analys
Enquiry Before Buy
image
Can´t read the image ? refresh here.